Autonomic neuropathy is associated with increased cardiovascular risk factors: The EURODIAB IDDM Complications Study

Diabetic Medicine

Volumn 19, Issue 11, 2002, Pages 900-909

  Kempler, P ^d   Tesfaye, S ^a   Chaturvedi, N ^b   Stevens, L K ^b   Webb, D J ^b   Eaton, S ^a   Kerenyi Zs ^c   Tamas Gy ^d   Ward, J D ^a   Fuller, J H ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Szent Imre Hospital   (Hungary)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Albumin excretion rate; Cardiovascular disease; Diabetic autonomic neuropathy; Plasma lipids; Type 1 (insulin dependent) diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HEART RATE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPERTENSION; PATHOLOGICAL REFLEX; PREVALENCE; PROTEINURIA; QUESTIONNAIRE; RECUMBENCY; RETINOPATHY; RISK FACTOR; SEX DIFFERENCE; STANDING; SYMPTOM; SYSTOLIC BLOOD PRESSURE; VERTIGO;

ADOLESCENT; ADULT; AGE OF ONSET; BLOOD PRESSURE; BODY CONSTITUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; EUROPE; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 18744412089     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00821.x     Document Type: Article

References (44)

1. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.
2. Ziegler D. Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment. Diabetes Metab Rev 1994; 10: 339-383.
3. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 2001; 24: 339-343.
4. Vinik AI, Zola BE. The effects of diabetic autonomic neuropathy on the cardiovascular system. In: Schwartz CJ, Born GVR, eds. New Horizons in Diabetes Mellitus and Cardiovascular Disease. London: Current Science Ltd, 1995: 159-171.
5. Mathias CJ. Autonomic disorders and their recognition. N Engl J Med 1997; 336: 721-724.
6. Hendrickse MT, Thuluvath PJ, Triger DR. The natural history of autonomic neuropathy in chronic liver disease. Lancet 1992; 339: 1462-1464.
7. EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 1994; 37: 278-285.
8. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C et al. and the EURODIAB IDDM Study Group. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
9. Stephenson JM, Kempler P, Cavallo Perin P, Fuller JH. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1372-1376.
10. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK for the EURODIAB IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study. Diabetologia 1995; 38: 437-444.
11. Bloom S, Till S, Sonksen P, Smith S. Use of a biothesiometer to measure individual vibration threshold and their variation in 519 non-diabetic. Br Med J 1984; 288: 1793-1795.
12. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46: 1470.
13. American Diabetes Association, American Academy of Neurology consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988; 11: 592-596.
14. Kempler P, Váradi A, Tamás Gy. Autonomic neuropathy in newly diagnosed diabetes mellitus. Diabetes Care 1993; 16: 848-849.
15. Neil HAW, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: The prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989; 6: 20-24.
16. Ziegler D, Gries FA, Mühlen H, Rathmann W, Spüler M, Lessmann F and the DIACAN Multicenter Study Group. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 1993; 19: 143-151.
17. Spallone V, Maiello MR, Cicconetti E, Menzinger G. Autonomic neuropathy and cardiovascular risk factors in insulin dependent and non-insulin-dependent diabetes. Diab Res Clin Pract 1997; 34: 169-179.
18. Ewing DJ, Marty CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 Years experiences in diabetes. Diabetes Care 1985; 8: 491-498.
19. Bergström B, Lilja B, Österlin S, Sundkvist G. Autonomic neuropathy in type I diabetes: Influence of duration and other diabetic complications. Acta Med Scand 1987; 222: 147-154.
20. Masaoka S, Lev-Ram A, Hill LR, Vakil G, Hon EHG. Heart rate variability in diabetes: Relationship to age and duration of the disease. Diabetes Care 1985; 8: 64-68.
21. Maser RE, Pfiefer MA, Dorman JS, Kuller RH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Arch Intern Med 1990; 150: 1218-1222.
22. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer Pet al. Assessment of cardiovascular autonomic function: Age related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992; 9: 166-175.
23. Reichard P, Jensen-Urstad K, Ericsson M, Jensen Urstad M, Lindblad LE. Autonomic neuropathy - A complication less pronounced in patients with type 1 diabetes mellitus who have lower blood glucose levels. Diabet Med 2000; 17: 860-866.
24. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetic therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial. Diabetologia 1988; 41: 416-423.
25. Kempler P, Hermányi Zs, Keresztes K, Marton A. Klinische und prognostische bedeutung der kardialen autonomen neuropathie. In: Gries FA, Federlin K, eds. Benfotiamin in der Therapie von Polyneuropathien. Stuttgart-New York: Thieme-Verlag, 1998: 39-44.
26. Page MM, Watkins PJ. Autonomic dysfunction in diabetic ketoacidosis. Lancet 1976; I: 963.
27. Krolewski AS, Barzilay J, Warram JH, Martin BC, Pfeifer M, Rand LI. Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes 1991; 41: 430-437.
28. Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993; 16: 773-779.
29. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S, Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normointensive IDDM patients. Diabetes Care 1994; 17: 578-584.
30. Stella P, Ellis D, Maser RE, Orchard TJ. Cardiac autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diab Comp 2000; 14: 1-6.
31. Jermendy Gy, Ferenczy J, Hernandez E, Farkas K, Nádas J. Day-night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic autonomic neuropathy. Diabetes Res Clin Pract 1996; 34: 107-114.
32. Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL. Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care 1999; 22: 1745-1747.
33. Airaksinen KEJ. Silent coronary artery disease in diabetes - A feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 2001; 44: 259-266.
34. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 1996; 45: 801-805.
35. Kahn JK, Zola B, Juni JE, Vinik AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 1986; 7: 1303-1309.
36. Gonin JM, Kadrofske M, Schmaltz S, Bastyr EJ, Vinik AI. Corrected QT interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 1990; 13: 68-71.
37. Kempler P, Váradi A, Szalay F, Tamás Gy. Autonomic neuropathy and corrected QT interval prolongation: There is a relationship. Diabetes Care 1994; 17: 454-456.
38. Kempler P, Váradi A, Szalay F. Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet 1992; 340: 318.
39. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3-17.
40. Kleiger RE, Miller JP, Bigger JT, Moss AJ, the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262.
41. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478-484.
42. Lengyel Cs, Török T, Várkonyi T, Kempler P, Rudas L. Baroreflex sensitivity and heart-rate variability in insulin-dependent diabetics with polyneuropathy. Lancet 1998; 351: 1436-1437.
43. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 Years experience in diabetes. Diabetes Care 1985; 8: 491-498.
44. Valensi P, Attali JR, Gagant S and the French Group for Research and Study of Diabetic Neuropathy. Reproducibility of parameters for assessment of diabetic neuropathy. Diabet Med 1993; 10: 933-939.